Preferred Label : silodosin;
UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;
Is substance : O;
Origin ID : M0505454;
UMLS CUI : C1870115;
Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- MeSH narrower concept(s)
- Related MeSH concept(s)
- Related record
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
http://www.has-sante.fr/portail/jcms/c_2569213/fr/silodyx
http://www.has-sante.fr/portail/jcms/c_957057/silodyx
2015
false
France
French
prostatic hypertrophy, benign
adult
receptors, adrenergic, alpha-1
silodosin
indoles
administration, oral
silodosin
insurance, health, reimbursement
prostatic hyperplasia
treatment outcome
silodosin
indoles
adrenergic alpha-1 receptor antagonists
adrenergic alpha-1 receptor antagonists
silodosin
silodosin
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_2569219/fr/urorec
http://www.has-sante.fr/portail/jcms/c_957056/urorec
2015
false
France
French
prostatic hypertrophy, benign
adult
silodosin
silodosin
indoles
indoles
receptors, adrenergic, alpha-1
prostatic hyperplasia
administration, oral
insurance, health, reimbursement
treatment outcome
silodosin
adrenergic alpha-1 receptor antagonists
adrenergic alpha-1 receptor antagonists
silodosin
silodosin
evaluation of the transparency committee
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65024515
2012
France
summary of product characteristics
package leaflet
capsules
silodosin
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69141416
2012
France
summary of product characteristics
package leaflet
capsules
silodosin
---
https://www.ema.europa.eu/medicines/human/EPAR/Urorec
2012
United Kingdom
French
English
syndication feed
indoles
indoles
silodosin
silodosin
capsules
administration, oral
drug approval
treatment outcome
drug labeling
drug interactions
adult
aged
receptors, adrenergic, alpha-1
prostatic hyperplasia
silodosin
adrenergic alpha-1 receptor antagonists
adrenergic alpha-1 receptor antagonists
silodosin
silodosin
drug evaluation
summary of product characteristics
package leaflet
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63911098
2012
France
summary of product characteristics
package leaflet
capsules
silodosin
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61605245
2012
France
summary of product characteristics
package leaflet
capsules
silodosin
---
https://www.ema.europa.eu/medicines/human/EPAR/Silodyx
2012
United Kingdom
English
French
syndication feed
silodosin
silodosin
indoles
indoles
prostatic hyperplasia
capsules
administration, oral
drug approval
treatment outcome
drug labeling
adult
aged
drug interactions
receptors, adrenergic, alpha-1
silodosin
adrenergic alpha-1 receptor antagonists
adrenergic alpha-1 receptor antagonists
silodosin
silodosin
drug evaluation
package leaflet
summary of product characteristics
---
Summary Basis of Decision (SBD) RAPAFLO - Silodosin, 8 mg and 4 mg capsules
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00120
2011
false
Canada
French
English
drug evaluation
indoles
indoles
prostatic hyperplasia
clinical trials, phase iii as topic
randomized controlled trials as topic
silodosin
administration, oral
drug approval
treatment outcome
risk assessment
silodosin
silodosin
adrenergic alpha-1 receptor antagonists
adrenergic alpha-1 receptor antagonists
silodosin
silodosin
---
